Eosinophilic esophagitis: Concepts, controversies, and evidence

Current Gastroenterology Reports

Volumn 11, Issue 3, 2009, Pages 220-225

  Putnam, Philip E ^a   Rothenberg, Marc E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BUDESONIDE; CROMOGLYCATE DISODIUM; EOTAXIN 3; FLUTICASONE; INTERLEUKIN 13; INTERLEUKIN 15; MONTELUKAST; PLACEBO; PROTON PUMP INHIBITOR; STEROID;

ASTHMA; ATOPIC DERMATITIS; ATOPY; CHRONIC RHINITIS; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL TRIAL; DIET RESTRICTION; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DOWN REGULATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DYSPHAGIA; ELEMENTAL DIET; ENDOSCOPY; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS CANDIDIASIS; ESOPHAGUS STRICTURE; FIBROSIS; FOOD ALLERGY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL BIOPSY; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HYPERSENSITIVITY; IMAGE ANALYSIS; IMMUNE RESPONSE; LAMINA PROPRIA; LOW DRUG DOSE; MICROARRAY ANALYSIS; MILK; NONHUMAN; NUT; NUTRITIONAL VALUE; PATHOGENESIS; PATIENT COMPLIANCE; PATIENT EDUCATION; QUALITY OF LIFE; REMISSION; REVIEW; SHELLFISH; SOYBEAN; TREATMENT FAILURE; TREATMENT RESPONSE; UPREGULATION;

ANTI-INFLAMMATORY AGENTS; BALLOON DILATATION; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; ESOPHAGITIS; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HISTAMINE ANTAGONISTS; HUMANS; HYPERSENSITIVITY; INTESTINAL MUCOSA; PROTON PUMP INHIBITORS; RISK FACTORS; TREATMENT OUTCOME;

EID: 66149119039     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-009-0034-2     Document Type: Review

References (33)

1. Kelly KJ, Lazenby AJ, Rowe PC, et al.: Eosinophilic esophagitis attributed to gastroesophageal reflux: Improvement with an amino acid-based formula. Gastroenterology 1995, 109:1503-1512.
2. Noel RJ, Putnam PE, Rothenberg ME.: Eosinophilic esophagitis. N Engl J Med 2004, 351:940-941.
3. Cherian S, Smith NM, Forbes DA.: Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia. Arch Dis Child 2006, 91:1000-1004.
4. Kapel RC, Miller JK,ATorres C, et al.: Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology 2008, 134:1316-1321.
5. Furuta GT, Liacouras CA, Collins MH, et al.: Eosinophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment. First International Gastrointestinal Eosinophil Research Symposium (FIGERS) Subcommittees. Gastroenterology 2007, 133:1342-1363.
6. Teitelbaum JE, Fox VL, Twarog FJ, et al.: Eosinophilic esophagitis in children: Immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002, 122:1216-1225.
7. Ngo P, Furuta GT, Antonioli DA, Fox VL: Eosinophils in the esophagus-peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 2006, 101:1666-1670.
8. Blanchard C, Wang N, Stringer KF, et al.: Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006, 116:536-547.
9. Blanchard C, Mingler MK, Vicario M, et al.: IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 2007, 120:1292-1300.
10. Fox VL: EosinophilicEesophagitis: endoscopic findings. Gastrointest Endosc Clin N Am 2008, 18:45-57.
11. Liacouras CA, Spergel JM, Ruchelli E, et al.: Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005, 3:1198-1206.
12. Gonsalves N, Policarpio-Nicolas M, Zhang Q, et al.: Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 2006, 64:313-319.
13. Khan S, Orenstein SR, Di Lorenzo C, et al.: Eosinophilic esophagitis: strictures, impactions, dysphagia. Dig Dis Sci 2003, 48:22-29.
14. Straumann A, Bussmann C, Zuber M, et al.: Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients. Clin Gastroenterol Hepatol 2008, 6:598-600.
15. Cohen MS, Kaufman AB, Palazzo JP, et al.: An audit of endoscopic complications in adult eosinophilic esophagitis. Clin Gastroenterol Hepatol 2007, 5:1149-1153.
16. Orenstein SR, Shalaby TM, Di Lorenzo C, et al.: The spectrum of pediatric eosinophilic esophagitis beyond infancy: A clinical series of 30 children. Am J Gastroenterol 2000, 95: 1422-1430. Erratum in: Am J Gastroenterol 2001, 96:2290.
17. Assa'ad AH, Putnam PE, Collins MH, et al.: Pediatric patients with eosinophilic esophagitis: An 8-year follow-up. J Allergy Clin Immunol 2007, 119:731-738.
18. Markowitz JE, Spergel JM, Ruchelli E, et al.: Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 2003, 98:777-782.
19. Spergel JM, Brown-Whitehorn T, Beausoleil JL, et al.: Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis. J Allergy Clin Immunol 2007, 119:509-511.
20. Spergel JM, Andrews T, Brown-Whitehorn TF, et al.: Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 2005, 95:336-343.
21. Konikoff MR, Blanchard C, Kirby C, et al.: Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006, 4:1328-1336.
22. Gupta SK, Fitzgerald JF, Kondratyuk T, et al.: Cytokine expression in normal and inflamed esophageal mucosa: A study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2006, 42:22-26.
23. Kagalwalla AF, Sentongo TA, Ritz S, et al.: Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006, 4:1097-1102.
24. Konikoff MR, Noel RJ, Blanchard C, et al.: A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006, 131:1381-1391.
25. Noel RJ, Putnam PE, Collins MH, et al.: Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2004, 2:568-575.
26. Schaefer ET, Fitzgerald JF, Molleston JP, et al.: Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: A randomized trial in children. Clin Gastroenterol Hepatol 2008, 6:165-173.
27. Aceves SS, Bastian AF, Newbury RO, Dohil R: Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol. 2007, 102:2271-2279.
28. Faubion WA Jr, Perrault J, Burgart LJ, et al.: Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr. 1998, 27:90-93.
29. Stein ML, Collins MH, Villanueva JM, et al.: Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 2006, 118:1312-1319.
30. Blanchard C, Mishra A, Saito-Akei H, et al.: Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin Exp Allergy 2005, 35:1096-1103.
31. Aceves SS, Newbury RO, Dohil R, et al.: Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2007, 119:206-212.
32. Straumann A, Spichtin HP, Grize L, et al.: Natural history of primary eosinophilic esophagitis: A follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003, 125:1660-1669.
33. Mishra A, Wang M, Pemmaraju VR, et al.: Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology 2008, 134:204-214.